In order to evaluate the activity of tumor specific cytotoxic T lymphocytes, we analyzed the hepatic expression levels of CD8, FasL, perforin and granzyme B, which are cytotoxic molecules used by CD8+ T lymphocytes, by performed quantitative RT-PCR analysis. The gene discussed is PRF1; the disease is neoplasm.